Suchergebnisse - "Doehn, Christian"

PubPharm (12)

1

Interdisciplinary recommendations for the treatment of advanced renal cell carcinoma

enthalten in: Aktuelle Urologie | 2022

von Miller, K. | Bergmann, L. | Doehn, C. | +4

2

Interdisciplinary recommendations for the treatment of advanced metastatic renal cell carcinoma

enthalten in: Aktuelle Urologie | 2020

von Miller, K. | Bergmann, L. | Doehn, C. | +5

3

50 years of renal cell carcinoma

enthalten in: Aktuelle Urologie | 2019

von Doehn, C.

4

Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus : The EVERPRO Study

enthalten in: Oncology research and treatment | 2019

von Goebell, P. | Hermann, E. | Kube, U. | +8

5

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Sternberg, C. | Donskov, F. | Haas, N. | +7

CommentIn: Clin Cancer Res. 2018 Jul 1;24(13):2979-2980. - PMID 29523625

6

Interdisciplinary Recommendations for the Treatment of Metastatic Renal Cell Carcinoma

enthalten in: Aktuelle Urologie | 2017

von Miller, K. | Bergmann, L. | Doehn, C. | +2

7

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

enthalten in: The New England journal of medicine | 2016

von Ravaud, A. | Motzer, R. | Pandha, H. | +103

CommentIn: Urology. 2017 Jul;105:13. - PMID 28089886

8

The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma

enthalten in: Deutsches Arzteblatt international | 2016

von Doehn, C. | Grünwald, V. | Steiner, T. | +3

CommentIn: Dtsch Arztebl Int. 2017 Mar 3;114(9):160. - PMID 28351469

9

Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy : results of an interim analysis of a non-interventional study

enthalten in: Onkologie | 2013

von Bergmann, L. | Goebell, P. | Kube, U. | +13

10

In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer

enthalten in: In vivo (Athens, Greece) | 2009

von Blietz, C. | Thode, B. | Hauses, M. | +5